In a nutshell
This study investigated the safety and effectiveness of Aquablation using the AquaBeam system for the treatment of lower urinary tract symptoms (LUTS) as a result of benign prostatic hyperplasia (BPH). The results suggested that Aquablation using the AquaBeam system was safe and effective.
Some background
LUTS is a collection of symptoms that may include overactive bladder, urine leakage (incontinence), or discomfort passing urine. It affects about 40% of men over 70. LUTS is often caused by BPH (an enlarged prostate gland).
Aquablation is used to treat BPH. This technology uses high-pressure liquid to remove the extra prostate tissue blocking urine flow. The AquaBeam system involves Aquablation guided by live imaging to increase the precision of the Aquablation. Whether Aquablation using the AquaBeam system was safe and effective in patients with LUTS due to BPH is still unknown.
Methods & findings
55 men with LUTS as a result of BPH were included in the study. Participants received 2 rounds of standard Aquablation with the AquaBeam system. This was followed by bladder washout with a continuous flow of liquid through a catheter. Patients were followed-up at 3 and 12 months after treatment.
There were significant reductions in prostate volume and LUTS symptoms following treatment. At the 12 month follow-up, the urinary flow rate had also improved. There was no change in sexual function following treatment.
14.5% of participants experienced side effects that required treatment. 9.1% experienced urinary retention (incapacity to empty the bladder). 5.5% developed urinary tract infections. 3.6% had blood in their urine which required a blood transfusion.
The bottom line
This study suggested that Aquablation with the AquaBeam system is safe and effective for the treatment of LUTS as a result of BPH.
The fine print
This study included a small number of patients treated by the same doctor at the same medical center. Therefore, the results may not be applicable to a larger group of patients treated elsewhere. Also, longer-term results are needed. This study was funded by PROCEPT BioRobotics, the manufacturer of the AquaBeam system.
What’s next?
If you have questions about the treatment of LUTS or BPH, please contact your doctor.
Published By :
World Journal of Urology
Date :
Jan 03, 2021
